InvestorsHub Logo
Followers 18
Posts 352
Boards Moderated 0
Alias Born 12/21/2020

Re: BadSnap post# 85557

Friday, 08/27/2021 10:01:20 PM

Friday, August 27, 2021 10:01:20 PM

Post# of 118425
Depends on how you value the company with the patents they hold. There are companies trading NASDAQ with 1 mRNA patent that are valued at $12B. RGBP has multiple patents. But regardless of the number of patents, if you valued the company at $12b that would give us a share price of over $3 a share based on the current O/S which actually isn't awful

All hypothetical, but there are comparisons you can make between this and other companies where I think with the multiple patents RGBP could be worth much more than $12b.